Epitalon
Aliases: Epithalon · Epithalone · AEDG peptide
Last verified: 2026-09-23
The short version
Epitalon is the center of the 'bioregulator' narrative: claimed to lengthen telomeres, reactivate telomerase and extend lifespan. These claims rest on old Russian work with weak methodology and community anecdote. Western science has not replicated the telomerase findings in rigorous models; there are no controlled human trials. What is true: there is no evidence it is harmful in short protocols, but also none that it does anything attributed to it.
Identity & type
- Molecular type
- analog
- Sequence / structure
- Ala-Glu-Asp-Gly (4 aa)
- Molecular weight
- ~390 Da
- Origin
- Tetrapeptide 'epitalon', the putative peptide factor of the pineal gland; developed in the Khavinson program.
Mechanism of action
Induces hTERT expression → telomerase activation; modulates melatonin, MMP enzymes and antioxidant systems (pineal action).
not confirmed in humans
Dosing & routes
Official / clinical context
No approved official document exists for Epitalon. Any protocols mentioned are to be read as information, not as a recommendation.
Regulator-approved labeling and published study designs — never a recommendation.
Community-reported practice
Classic protocol: 5–10 mg/day SC for 10–20 days, 1–2 courses yearly. 10–20-day courses: most commonly reported are better sleep, circadian-rhythm normalization and an "overall tone" in older users; younger users rarely notice a difference.
Unverified self-reports. Not medical advice. Not endorsement.
Expected effects (community)
10–20-day courses: most commonly reported are better sleep, circadian-rhythm normalization and an "overall tone" in older users; younger users rarely notice a difference.
Protocol — official vs community
Official / label
No approved protocol outside Russia (where epithalamin saw geriatric use). The research literature uses 5–10 mg SC daily for 10–20 day courses.
- 0110-day course: 5–10 mg SC daily
Duration: Course-based, 1–2 courses per year in the Russian geriatric tradition.
The course structure comes from the Khavinson school; independent replication is absent.
Community (anecdotal)
5–10 mg SC daily for 10–20 days, or 1–2 mg for longer; oral and nasal forms marketed with unproven bioavailability.
- Cycle:
- 1–2× per year, frequently paired with pinealon in longevity circles.
- Break:
- Months between courses — built into the model.
One of the few bioregulator patterns with an actual published schedule — even if the evidence behind it is one-school science.
Human evidence
No controlled human trials; the only 'data' come from old Soviet programs with unclear methodology.
Preclinical evidence
Work of Prof. Khavinson's group: lifespan extension in rodents, melatonin normalization in the elderly; limited independent Western replication.
Known risks
- No significant adverse effects documented in short protocolscharacterized
- Telomerase stimulation, if real, would carry a bidirectional risk (regeneration and malignancy)theoretical
Teal: characterized in clinical/labeling contexts. Amber: theoretical or reported outside controlled settings.
Unknowns & evidence gaps
- Everything — no replicated human data
Frequently asked questions
References
- Khavinson V., early work on pineal peptides (not replicated)